中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2013, 25(7): 648-653
间充质干细胞在血液病治疗中的应用及研究现状
温晓文,吴迪炯,叶宝东,周郁鸿*
(浙江中医药大学第一临床医学院,杭州 310006)
摘 要:间充质干细胞(mesenchymal stem cells, MSCs) 具有免疫抑制、支持造血、促进微血管形成、抑制肿瘤细胞增殖等功能。在部分血液病中,MSCs 存在质和量的异常。MSCs 的应用使得良性血液病( 再生障碍性贫血、免疫性血小板减少症等)、恶性血液病以及造血干细胞(HSC) 移植的临床疗效得到进一步的提高,并正在不断推广应用,但部分疗效机制及安全性仍有待于深入探讨。
    关键词:间充质干细胞;血液病;疗效机制
 
Advance of MSCs in the treatment of hematologic diseases
WEN Xiao-Wen, WU Di-Jiong, YE Bao-Dong, ZHOU Yu-Hong*
(The First Clinical Medical School, Zhejiang Chinese Medical University, Hangzhou 310006, China)
Abstract: Mesenchymal stem cells (MSCs) present various biological functions such as immune suppression,hematopoiesis supporting, angiogenesis promotion and tumor inhibition. Quantitative and qualitative abnormality of MSCs plays an important role in the pathogenesis of some hematologic diseases. With the application of MSCs, the therapeutic effects on non-malignant hematological diseases (aplastic anemia,immune thrombocytopenia),hematologic malignancies and the hemopoietic stem cell transplantation have been improved significantly, while the mechanism and the safety are still needed to be explored.
    Key words: mesenchymal stem cells; hematologic diseases; therapeutic mechanism
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2957876 位访问者,欢迎!